Inventor · disambiguated record
Angel Francisco Lopez
Also filed as: LOPEZ ANGEL · LOPEZ ANGEL F · LOPEZ ANGEL FRANCISCO
15 granted patents·29 pending applications·170 citations·filing 1992–2024
92Inventor score
Files withMEDVET SCIENCE PTY LTD14CSL LTD8CENTRAL ADELAIDE LOCAL HEALTH NETWORK INC5PREC MEDICINE HOLDINGS PTY LTD3CSL Innovation Pty Ltd2
Top patents by PatentIndex Score
44 records- 0185US2025122295A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2024·Application pending·0 cites
- 0282US9920371B2Screening methodMEDVET SCIENCE PTY LTD·Filed 2012·Granted Mar 20, 2018·4 cites·2 claims
- 0382US6177078B1Monoclonal antibody antagonists to IL-3MEDVET SCIENCE PTY LTD·Filed 1996·Granted Jan 23, 2001·75 cites·10 claims
- 0481US7427401B2Method of modulating leukemic cell and eosinphil activity with monoclonal antibodiesMEDVET SCIENCE PTY LTD·Filed 2004·Granted Sep 23, 2008·9 cites·2 claims
- 0579US11274346B2Screening methodPREC MEDICINE HOLDINGS PTY LTD·Filed 2019·Granted Mar 15, 2022·1 cites·3 claims
- 0677US2024076393A1Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorCENTRAL ADELAIDE LOCAL HEALTH NETWORK INC·Filed 2023·Application pending·0 cites
- 0775US10494674B2Screening methodPREC MEDICINE HOLDINGS PTY LTD·Filed 2018·Granted Dec 3, 2019·1 cites·5 claims
- 0875US6720155B1Monoclonal antibody inhibitor of GM-CSF, IL-3, IL-5 and other cytokines, and uses thereofFiled 1999·Granted Apr 13, 2004·29 cites·4 claims
- 0972US2020277389A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2019·Application pending·0 cites
- 1071US2022251659A1Screening methodPREC MEDICINE HOLDINGS PTY LTD·Filed 2022·Application pending·0 cites
- 1171US2021292424A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2021·Application pending·0 cites
- 1265US2021317218A1Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorCENTRAL ADELAIDE LOCAL HEALTH NETWORK INC·Filed 2021·Application pending·0 cites
- 1365US2015093355A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2014·Application pending·0 cites
- 1465US2017362328A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2017·Application pending·0 cites
- 1562US7220829B2Cytokine binding domain of cytokine receptorsMEDVET SCIENCE PTY LTD·Filed 2001·Granted May 22, 2007·3 cites·18 claims
- 1661US2016304616A1Method of treatment of philadelphia chromosome positive leukemiaCSL LTD·Filed 2016·Application pending·0 cites
- 1759US2018155435A1Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorCentral Adelaide Local Health Network·Filed 2017·Application pending·0 cites
- 1859US2015232564A1Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorCENTRAL ADELAIDE LOCAL HEALTH NEWORK INC·Filed 2015·Application pending·0 cites
- 1958US2020055943A1Regulating il-4 and il-13 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorCENTRAL ADELAIDE LOCAL HEALTH NETWORK INC·Filed 2019·Application pending·0 cites
- 2057US6200567B1Therapeutic agents as cytokine antagonists and agonistsMEDVET SCIENCE PTY LTD·Filed 1997·Granted Mar 13, 2001·15 cites·5 claims
- 2157US2014023658A1Regulating il-4 and il-3 levels by blocking high affinity binding by il-3, il-5 and gm-csf to their common receptorLOPEZ ANGEL·Filed 2013·Application pending·0 cites
- 2256US8489339B2Crystalline composition of GM-CSF/GM-CSFRHANSEN GUIDO·Filed 2007·Granted Jul 16, 2013·1 cites·6 claims
- 2355US2025236667A1Antibodies to mutant calreticulin and uses thereofCENTRAL ADELAIDE LOCAL HEALTH NETWORK INC·Filed 2022·Application pending·0 cites
- 2454US5591427AHuman Interleukin-3(Il-3) variants and their use to promote or antagonize IL-3-mediated processesMEDVET SCIENCE PTY LTD·Filed 1992·Granted Jan 7, 1997·16 cites·19 claims
- 2552US2016031996A1Anti il-3r alpha agents and uses thereofCSL LTD·Filed 2014·Application pending·0 cites
- 2652US2012244116A1Method of treatment of philadelphia chromosome positive leukaemiaHIWASE DEVENDRA KESHAORAO·Filed 2010·Application pending·0 cites
- 2751US2023406943A1Methods for treating inflammatory skin conditionsCSL Innovation Pty Ltd·Filed 2021·Application pending·0 cites
- 2848US2018244786A1Anti il-3r alpha agents and uses thereofCSL LTD·Filed 2017·Application pending·0 cites
- 2946US2024197771A1Compositions and uses thereofPANT HARSHITA·Filed 2022·Application pending·0 cites
- 3045US2023416381A1Methods for treating or preventing acute respiratory distress syndromeCSL Innovation Pty Ltd·Filed 2021·Application pending·0 cites
- 3143US2007059796A1Binding motif and methods of regulating cell functionMEDVET SCIENCE PTY LTD·Filed 2004·Application pending·0 cites
- 3242US2002177166A1Binding motif of a receptorMEDVET SCIENCE PTY LTD·Filed 2002·Application pending·0 cites
- 3341US5939063AModified forms of granulocyte macrophage-colony stimulating factor as antagonistsMEDVET SCIENCE PTY LTD·Filed 1994·Granted Aug 17, 1999·6 cites·9 claims
- 3441US2007219117A1Bidentate motif and methods of useMEDVET SCIENCE PTY LTD·Filed 2004·Application pending·0 cites
- 3540US2020079858A1Antibody conjugate for treating and detecting bladder cancerUNIV SOUTH AUSTRALIA·Filed 2018·Application pending·0 cites
- 3640US2013231305A1Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting PhosphorylationWOODCOCK JOANNA·Filed 2011·Application pending·0 cites
- 3737US2014348793A1Method of TreatmentMEDVET SCIENCE PTY LTD·Filed 2012·Application pending·0 cites
- 3835US2017173053A1Method of Modulating Protein 14-3-3 Functionality By Facilitating or Inhibiting PhosphorylationCENTRAL ADELAIDE LOCAL HEALTH NETWORK INC·Filed 2016·Application pending·0 cites
- 3934US2016053318A1Markers of endothelial progenitor cells and uses thereofMEDVET SCIENCE PTY LTD·Filed 2015·Application pending·0 cites
- 4030US6465616B1Interleukin-5 antagonistBRESAGEN LTD·Filed 1997·Granted Oct 15, 2002·5 cites·16 claims
- 4130US6322791B1Haemopoietic growth factor antagonists and uses thereforBREASAGEN LTD·Filed 1996·Granted Nov 27, 2001·5 cites·17 claims
- 4228US10583115B2Modulators of 14-3-3 functionality and uses thereofUNIV SOUTH AUSTRALIA·Filed 2015·Granted Mar 10, 2020·0 cites·7 claims
- 4327US2017218340A1Method of culturing cellsMEDVET SCIENCE PTY LTD·Filed 2015·Application pending·0 cites
- 4426USRE39433ETherapeutic agents as cytokine antagonists and agonistsMEDVET SCIENCE PTY LTD·Filed 1997·Granted Dec 19, 2006·0 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Angel Francisco Lopez files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →